To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene WDR43TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
228 supporting clones for gene WDR43 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA654485   .a 1 to 564 2 to 565   tiling clone, capped   564/564
(100 %)
1 diff
(99.9 %id)
DB444020 testis .a 20 to 472 1 to 453       453/453
(100 %)
2 diff
(99.6 %id)
DA098222 cerebellum .a 22 to 584 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA645333   .a 22 to 584 2 to 564   capped   563/565
(99 %)
1 diff
(99.9 %id)
DA819994   .a 22 to 572 2 to 552   capped   551/551
(100 %)
2 diff
(99.7 %id)
DA843281 placenta .a 22 to 588 2 to 569   capped   568/568
(100 %)
4 diff
(99.3 %id)
DA667581 esophagus .a 23 to 590 2 to 570   capped   569/569
(100 %)
4 diff
(99.3 %id)
DA726708   .a 23 to 549 2 to 529   capped   528/528
(100 %)
1 diff
(99.9 %id)
DB163799 thymus .a 23 to 592 2 to 571   capped   570/570
(100 %)
3 diff
(99.5 %id)
DB235303 trachea .a 23 to 486 2 to 465   capped   464/464
(100 %)
1 diff
(99.8 %id)
NM_015131.1   .a 24 to 3524 1 to 3501 exact RefSeq,   3501/3501
(100 %)
0 diff
(100 %id)
DA240106 brain .a 25 to 599 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DA607422   .a 25 to 572 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
DA617226   .a 25 to 588 2 to 566   capped   565/565
(100 %)
3 diff
(99.5 %id)
DA936798 Spleen .a 25 to 604 2 to 588   capped   587/587
(100 %)
7 diff
(98.9 %id)
DA943836 Spleen .a 25 to 596 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DB091547 testis .a 25 to 572 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DB122812 thymus .a 25 to 661 2 to 638   capped   637/646
(98 %)
1 diff
(99.9 %id)
DB229759 trachea .a 25 to 613 2 to 589   capped   588/588
(100 %)
3 diff
(99.5 %id)
DB233960 trachea .a 25 to 625 2 to 602   capped   601/601
(100 %)
1 diff
(99.9 %id)
DB268222 uterus .a 25 to 564 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
DB276454 uterus .a 25 to 560 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
D26488   .a 27 to 3524 1 to 3496 exact tiling clone, available from KIAA,   3496/3500
(99 %)
6 diff
(99.9 %id)
DA039505 bladder .a 29 to 490 2 to 463   capped   462/462
(100 %)
0 diff
(100 %id)
CR618449 Placenta Cot 25-normalized .a 29 to 1089 1 to 1061       1061/1061
(100 %)
0 diff
(100 %id)
AL549324 placenta, Placenta Cot 25-normalized .a 29 to 571 1 to 542   fully sequenced,   542/542
(100 %)
3 diff
(99.5 %id)
DA804653 brain .a 31 to 594 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
DA822057 pericardium .a 37 to 611 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DA912446   .a 37 to 603 2 to 569   capped   568/568
(100 %)
3 diff
(99.5 %id)
DB238221 trachea .a 37 to 604 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
BU076590 Pancreas, Purified pancreatic islet .a 38 to 622 1 to 585       585/585
(100 %)
7 diff
(98.9 %id)
DB280860 uterus .a 39 to 580 2 to 544   capped   543/543
(100 %)
2 diff
(99.7 %id)
DW448570 Liver .a 41 to 233 15 to 207       193/207
(93 %)
7 diff
(96.7 %id)
BX475447   .a 43 to 430 1 to 389       389/389
(100 %)
1 diff
(99.8 %id)
BX475682   .a 43 to 501 1 to 459       459/459
(100 %)
0 diff
(100 %id)
BX403617 placenta .a 44 to 1075 1 to 1024       1024/1033
(99 %)
26 diff
(97.5 %id)
BQ053985 blood, natural killer cells, cell line .a 45 to 970 1 to 935       935/1048
(89 %)
18 diff
(98.3 %id)
BF699660 brain, primitive neuroectoderm .a 46 to 745 1 to 700       698/881
(79 %)
28 diff
(96.9 %id)
DA474078   .a 47 to 619 2 to 575   capped   574/575
(99 %)
2 diff
(99.7 %id)
DA798778 brain .a 47 to 589 2 to 544   capped   543/543
(100 %)
2 diff
(99.7 %id)
DA048836   .a 48 to 600 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
DA238030 brain .a 48 to 632 2 to 591   capped   590/590
(100 %)
6 diff
(99.0 %id)
DA648559   .a 48 to 592 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA654109   .a 48 to 645 2 to 600   capped   599/599
(100 %)
1 diff
(99.9 %id)
DA728843   .a 48 to 894 2 to 852   capped   851/853
(99 %)
13 diff
(98.5 %id)
DA934422 Spleen .a 48 to 630 2 to 584   capped   583/583
(100 %)
3 diff
(99.5 %id)
DB219828 trachea .a 48 to 596 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DB251435 uterus .a 48 to 584 2 to 539   capped   538/538
(100 %)
3 diff
(99.5 %id)
BG104156 melanotic melanoma, skin .a 49 to 660 1 to 615       615/916
(67 %)
25 diff
(97.3 %id)
BG475265 melanotic melanoma, skin .a 49 to 661 1 to 611       611/617
(99 %)
7 diff
(98.9 %id)
BG476401 melanotic melanoma, skin .a 49 to 872 1 to 825       825/826
(99 %)
3 diff
(99.7 %id)
BG477404 melanotic melanoma, skin .a 49 to 904 1 to 871       871/918
(94 %)
31 diff
(96.7 %id)
BX443629 T cells (Jurkat cell line) .a 50 to 776 1 to 735       735/735
(100 %)
23 diff
(96.9 %id)
BF794950 lymph, lymphoma, cell line .a 50 to 815 1 to 763   AAA   763/763
(100 %)
11 diff
(98.6 %id)
BM788301 stomach .a 52 to 750 1 to 698       698/698
(100 %)
3 diff
(99.6 %id)
BG323976 Kidney, renal cell adenocarcinoma .a 53 to 880 1 to 829       829/854
(97 %)
23 diff
(97.4 %id)
DA679092   .a 53 to 612 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
DA755710   .a 53 to 386 2 to 335   capped   334/334
(100 %)
0 diff
(100 %id)
DA924225 small intestine .a 53 to 584 2 to 536   capped   535/535
(100 %)
4 diff
(99.3 %id)
BM541477 leiomyosarcoma, uterus .a 54 to 899 15 to 878       864/1096
(78 %)
21 diff
(98.1 %id)
BQ430991 melanotic melanoma, skin .a 56 to 537 10 to 491       482/856
(56 %)
12 diff
(98.6 %id)
BP872899 embryonal kidney .a 57 to 635 1 to 578       578/582
(99 %)
4 diff
(99.4 %id)
CN313104 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 58 to 869 8 to 819       812/819
(99 %)
7 diff
(99.2 %id)
AL516199 brain, neuroblastoma, neuroblastoma cells .a 60 to 929 1 to 869       869/869
(100 %)
3 diff
(99.7 %id)
AL560415 B cells (Ramos cell line), B cells from Burkitt lymphoma .a 60 to 904 1 to 843       843/843
(100 %)
4 diff
(99.6 %id)
BX340270 Placenta Cot 25-normalized .a 62 to 972 1 to 911       911/911
(100 %)
10 diff
(99.0 %id)
TI_57166042   .a 63 to 859 54 to 864       809/868
(93 %)
25 diff
(97.2 %id)
CD515567 White Matter .a 64 to 904 1 to 843       843/869
(97 %)
4 diff
(99.6 %id)
AL515320 neuroblastoma, placenta .a 65 to 876 1 to 811       811/811
(100 %)
3 diff
(99.7 %id)
BF025694 melanotic melanoma, skin .a 68 to 801 1 to 734       734/798
(91 %)
11 diff
(98.7 %id)
BI835496 pooled pancreas and spleen .a 68 to 859 1 to 805       805/809
(99 %)
48 diff
(94.1 %id)
BE384100 melanotic melanoma, skin .a 70 to 355 1 to 284       284/284
(100 %)
2 diff
(99.3 %id)
BX357862 Placenta Cot 25-normalized .a 72 to 1039 1 to 963       963/1013
(95 %)
13 diff
(98.8 %id)
CR612320 fetal liver .a 73 to 2258 1 to 2186   tiling clone,   2186/2186
(100 %)
0 diff
(100 %id)
AL532397 brain, fetal liver, Liver, neuroblastoma cells .a 73 to 1142 1 to 1056       1056/1056
(100 %)
21 diff
(98.1 %id)
CN313102 embryonic stem cells, cell lines H1, H7, andH9 .a 76 to 566 1 to 491       491/491
(100 %)
3 diff
(99.4 %id)
CR988625 T-Lymphocytes .a 77 to 802 1 to 727       727/729
(99 %)
5 diff
(99.4 %id)
CX755205 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 80 to 805 1 to 726     Submitted on the opposite strand 726/726
(100 %)
2 diff
(99.8 %id)
CN482190 eye .a 81 to 714 1 to 634       634/634
(100 %)
1 diff
(99.9 %id)
AW839070 leiomios .a 142 to 425 319 to 36       284/319
(89 %)
0 diff
(100 %id)
BU431079 lymph .a 193 to 615 8 to 431       423/431
(98 %)
17 diff
(96.1 %id)
TI_154152851   .a 193 to 802 79 to 688       609/667
(91 %)
32 diff
(95.3 %id)
BU188794 melanotic melanoma, skin .a 267 to 815 1 to 549   AAA   549/549
(100 %)
0 diff
(100 %id)
AW853030 colon .a 286 to 870 583 to 1       583/632
(92 %)
8 diff
(98.8 %id)
BG825535 muscle, rhabdomyosarcoma .a 294 to 1143 1 to 843   available from MGC,   843/939
(89 %)
17 diff
(98.2 %id)
BG826406 muscle, rhabdomyosarcoma .a 294 to 1073 1 to 779       779/783
(99 %)
3 diff
(99.7 %id)
BQ083173 Ascites, stomach .a 294 to 657 1 to 363       363/363
(100 %)
6 diff
(98.4 %id)
AK000836 adipose tissue .a 304 to 2004 1 to 1700   available from FLJ, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1700/1703
(99 %)
12 diff
(99.3 %id)
BC033206 Muscle, rhabdomyosarcoma .a 305 to 1405 11 to 1111   available from MGC, AAA   1101/1101
(100 %)
2 diff
(99.9 %id)
BQ229502 embryonal carcinoma, cell line, testis .a 314 to 972 1 to 658       658/791
(83 %)
4 diff
(99.5 %id)
DB515023 testis .a 393 to 824 1 to 432     Submitted on the opposite strand 432/432
(100 %)
13 diff
(97.0 %id)
AL708293 human skeletal muscle .a 464 to 1063 1 to 598       598/598
(100 %)
3 diff
(99.5 %id)
BU520870 leiomyosarcoma, uterus .a 467 to 1232 1 to 774       774/876
(88 %)
13 diff
(98.6 %id)
AL573599 placenta, Placenta Cot 25-normalized .a 510 to 1089 580 to 1   fully sequenced,   580/580
(100 %)
7 diff
(98.8 %id)
BM011908 brain, neuroblastoma, cell line .a 510 to 1290 1 to 785       785/786
(99 %)
17 diff
(97.9 %id)
TI_59381092   .a 511 to 1290 96 to 879       784/785
(99 %)
16 diff
(98.0 %id)
CB126579 Liver .a 512 to 974 1 to 463       463/463
(100 %)
1 diff
(99.8 %id)
CB126726 Liver .a 512 to 990 1 to 479       479/479
(100 %)
3 diff
(99.4 %id)
D87716 bone marrow .a 521 to 3524 1 to 3004   available from KIAA,   3004/3004
(100 %)
9 diff
(99.8 %id)
DA473355   .a 544 to 1101 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BM825148 Ascites, stomach .a 584 to 1292 1 to 709       709/709
(100 %)
1 diff
(99.9 %id)
BE408569 choriocarcinoma, placenta .a 613 to 1275 1 to 658       659/659
(100 %)
6 diff
(99.1 %id)
BX496321 Liver .a 641 to 1152 1 to 512       512/512
(100 %)
1 diff
(99.9 %id)
BX411450 fetal liver, Liver .a 653 to 1498 856 to 1       857/887
(96 %)
39 diff
(95.7 %id)
BF175990 blood .a 660 to 1069 1 to 407       407/407
(100 %)
5 diff
(98.8 %id)
BM796822 Ascites, stomach .a 714 to 1329 1 to 615       615/615
(100 %)
2 diff
(99.7 %id)
BF965470 Bone, osteosarcoma, cell line .a 716 to 1352 1 to 635       635/635
(100 %)
6 diff
(99.1 %id)
AA468890 colon .a 755 to 1405 650 to 1       650/650
(100 %)
15 diff
(97.7 %id)
BM454777 leiomyosarcoma, uterus .a 766 to 1469 1 to 715       715/1071
(66 %)
19 diff
(98.3 %id)
CA429276 Cell Line, Chondrosarcoma .a 775 to 1405 646 to 17   AAA   630/630
(100 %)
4 diff
(99.4 %id)
BE796672 lung, small cell carcinoma .a 800 to 1587 1 to 779       779/925
(84 %)
23 diff
(97.6 %id)
BM473523 duodenal adenocarcinoma, cell line, small intestine .a 811 to 1799 1 to 988       988/1072
(92 %)
12 diff
(98.9 %id)
CB144007 Liver .a 813 to 1203 1 to 393       393/393
(100 %)
3 diff
(99.3 %id)
DB508928 testis .a 959 to 1405 1 to 447     Submitted on the opposite strand 447/447
(100 %)
9 diff
(98.0 %id)
BX432011 fetal liver, Liver .a 969 to 1678 1 to 710       710/887
(80 %)
9 diff
(99.0 %id)
BE697647 colon .a 1016 to 1136 1 to 119       119/131
(90 %)
5 diff
(96.2 %id)
BE697650 colon .a 1020 to 1134 27 to 138       112/138
(81 %)
6 diff
(95.7 %id)
BG743644 skin .a 1068 to 1854 1 to 786       786/786
(100 %)
3 diff
(99.7 %id)
BX502509 Liver .a 1080 to 1779 1 to 699       699/699
(100 %)
8 diff
(98.9 %id)
BF736048 bladder_tumor .a 1160 to 1758 1 to 610       588/610
(96 %)
78 diff
(87.3 %id)
AL121450 melanoma (MeWo cell line) .a 1179 to 1543 1 to 365       365/365
(100 %)
2 diff
(99.5 %id)
FN066502 breast carcinoma .a 1188 to 1290 1 to 104       104/104
(100 %)
3 diff
(97.2 %id)
AW367262 head_neck .a 1199 to 1859 9 to 669       661/672
(98 %)
20 diff
(97.1 %id)
BM754426 stomach .a 1226 to 1667 1 to 441       441/441
(100 %)
2 diff
(99.6 %id)
GD141692   .a 1289 to 1411 1 to 122       122/131
(93 %)
3 diff
(97.8 %id)
GD153854   .a 1293 to 1411 7 to 125       119/127
(93 %)
10 diff
(92.2 %id)
AL516198 brain, neuroblastoma, neuroblastoma cells .a 1362 to 2282 920 to 1       920/920
(100 %)
8 diff
(99.2 %id)
AL532396 brain, fetal liver, Liver, neuroblastoma cells .a 1363 to 2258 903 to 1       903/1024
(88 %)
62 diff
(94.0 %id)
AL581865 B cells (Ramos cell line), B cells from Burkitt lymphoma .a 1385 to 2302 916 to 1       916/916
(100 %)
9 diff
(99.1 %id)
AW088023 esophagus, squamous cell carcinoma .a 1409 to 1989 581 to 1       581/581
(100 %)
2 diff
(99.7 %id)
CN313100 embryonic stem cells, DMSO-treated H9 cellline .a 1417 to 2090 1 to 674       674/674
(100 %)
1 diff
(99.9 %id)
T29045 prostate gland .a 1424 to 1716 1 to 293       293/293
(100 %)
0 diff
(100 %id)
AA156138 colon, tumor .a 1433 to 1856 1 to 424       424/425
(99 %)
1 diff
(99.8 %id)
BU508687 leiomyosarcoma, uterus .a 1448 to 2257 12 to 834       823/948
(86 %)
14 diff
(98.6 %id)
TI_149276938   .a 1492 to 2043 622 to 71   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 552/763
(72 %)
2 diff
(99.8 %id)
BM969052 lung, Primary Lung Epithelial Cells .a 1492 to 2043 557 to 6   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 552/561
(98 %)
2 diff
(99.7 %id)
BE349630 malignant melanoma, metastatic to lymphnode, skin .a 1493 to 1989 497 to 1       497/503
(98 %)
1 diff
(99.9 %id)
DB353889   .a 1494 to 1989 496 to 1       496/547
(90 %)
8 diff
(98.6 %id)
AI961936 adenocarcinoma, Pancreas .a 1585 to 1989 404 to 1       404/404
(100 %)
2 diff
(99.6 %id)
AW276385 lung, two pooled squamous cell carcinomas .a 1682 to 2316 635 to 1       635/635
(100 %)
4 diff
(99.4 %id)
BG503183 embryonal carcinoma, testis .a 1687 to 2243 1 to 558       558/558
(100 %)
4 diff
(99.3 %id)
BC024234 Testis, embryonal carcinoma .a 1687 to 3523 4 to 1839   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 1836/1837
(99 %)
4 diff
(99.8 %id)
BG532365 embryonal carcinoma, testis .a 1687 to 2462 1 to 787   available from MGC,   787/791
(99 %)
24 diff
(97.0 %id)
AI457359 colon, moderately-differentiated adenocarcinoma .a 1709 to 2307 600 to 1       600/600
(100 %)
8 diff
(98.7 %id)
AW118220 pooled .a 1748 to 2304 563 to 7       557/563
(98 %)
1 diff
(99.9 %id)
CN313101 embryonic stem cells, cell lines H1, H7, andH9 .a 1764 to 2451 15 to 703       689/703
(98 %)
8 diff
(98.9 %id)
BU176490 eye, retinoblastoma .a 1777 to 2653 24 to 903       880/903
(97 %)
9 diff
(99.1 %id)
TI_159695999   .a 1789 to 2310 623 to 101       523/1073
(48 %)
14 diff
(98.7 %id)
BG676498 skin, squamous cell carcinoma .a 1803 to 2516 1 to 715       715/775
(92 %)
5 diff
(99.4 %id)
AA580434 colon, colon tumor .a 1808 to 2306 499 to 1       499/499
(100 %)
2 diff
(99.6 %id)
BM739934 Ascites, stomach .a 1809 to 2391 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
BM756514 Ascites, stomach .a 1809 to 1994 1 to 186       186/186
(100 %)
1 diff
(99.5 %id)
BM738889 Ascites, stomach .a 1854 to 2376 1 to 524       522/524
(99 %)
3 diff
(99.5 %id)
BF031447 hypernephroma, Kidney .a 1860 to 2560 9 to 705       697/828
(84 %)
28 diff
(96.7 %id)
DB507365 testis .a 1890 to 2299 1 to 409   AAA Submitted on the opposite strand 409/409
(100 %)
12 diff
(97.1 %id)
AL515319 neuroblastoma, placenta .a 2775 to 3525 747 to 1   tiling clone,   747/747
(100 %)
15 diff
(98.0 %id)
BG760680 melanotic melanoma, high MDR (cell line), skin .b 1 to 787 1 to 786   tiling clone,   786/786
(100 %)
6 diff
(99.3 %id)
AA582856 germ cell tumor .b 713 to 1347 636 to 1       636/636
(100 %)
2 diff
(99.7 %id)
AA582857 germ cell tumor .b 713 to 1340 629 to 1   tiling clone,   629/629
(100 %)
2 diff
(99.7 %id)
GD155882   .b 1303 to 1363 1 to 62   tiling clone,   62/62
(100 %)
2 diff
(96.8 %id)
CU452575 epidermis .c 1 to 579 597 to 19 E177G tiling clone, Submitted on the opposite strand 579/610
(94 %)
2 diff
(99.7 %id)
DB059397 testis .d 1 to 542 2 to 543 exact tiling clone, capped   542/542
(100 %)
2 diff
(99.7 %id)
DB442514 testis .e 1 to 386 1 to 390   tiling clone,   390/390
(100 %)
12 diff
(97.0 %id)
DB024057 testis .e 24 to 581 2 to 559 exact tiling clone, capped   558/558
(100 %)
2 diff
(99.7 %id)
DB455935 testis .e 64 to 559 1 to 496   tiling clone,   496/496
(100 %)
2 diff
(99.6 %id)
DA321916 hippocampus .f-u 1 to 563 2 to 565   tiling clone, to resequence, capped   564/564
(100 %)
3 diff
(99.5 %id)
EH326676   .f-u 133 to 182 1 to 50   tiling clone,   50/50
(100 %)
0 diff
(100 %id)
DB521358 testis .f-u 1333 to 1644 1 to 314 K4R K5E N6E E7* tiling clone, Submitted on the opposite strand 314/314
(100 %)
8 diff
(97.5 %id)
W19428 lung .f-u 1391 to 1839 1 to 449 exact tiling clone,   449/449
(100 %)
2 diff
(99.6 %id)
AA044399 uterus .f-u 1410 to 1642 234 to 1       234/240
(97 %)
1 diff
(99.6 %id)
AW009935 colon .f-u 1438 to 1645 208 to 1       208/208
(100 %)
0 diff
(100 %id)
CD639866 pooled .f-u 1453 to 2084 1 to 626       626/729
(85 %)
9 diff
(98.8 %id)
AA156487 colon, tumor .f-u 1477 to 1943 469 to 1       469/473
(99 %)
2 diff
(99.6 %id)
FN170053 breast carcinoma .f-u 1556 to 1657 1 to 99       99/99
(100 %)
3 diff
(97.0 %id)
AA315159 colon .f-u 1574 to 2086 1 to 513   tiling clone,   513/513
(100 %)
0 diff
(100 %id)
AW949331   .f-u 1575 to 2099 1 to 522       522/522
(100 %)
3 diff
(99.5 %id)
FN138193 breast carcinoma .f-u 1586 to 1685 1 to 98       98/98
(100 %)
2 diff
(98.0 %id)
BG674140 skin .f-u 1729 to 2510 1 to 784       784/1045
(75 %)
6 diff
(99.5 %id)
BG036013 adenocarcinoma, cell line, Liver .f-u 1770 to 2524 1 to 751   tiling clone,   751/832
(90 %)
24 diff
(97.2 %id)
BF131103 hypernephroma, Kidney .f-u 1924 to 2514 1 to 587       587/868
(67 %)
15 diff
(98.3 %id)
CR748401   .f-u 2038 to 2404 1 to 367       367/371
(98 %)
1 diff
(99.8 %id)
AW385246 leiomios .f-u 2138 to 2475 1 to 339       339/339
(100 %)
4 diff
(98.9 %id)
TI_149305042   .f-u 2277 to 2863 709 to 130   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 580/901
(64 %)
8 diff
(99.2 %id)
BM978525 lung, Primary Lung Epithelial Cells .f-u 2277 to 2863 598 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 580/606
(95 %)
8 diff
(98.7 %id)
BX088756 breast .f-u 2280 to 2694 1 to 414       414/414
(100 %)
2 diff
(99.6 %id)
R83248 breast .f-u 2300 to 2794 1 to 496       496/496
(100 %)
21 diff
(95.8 %id)
DB309148 hippocampus .f-u 2398 to 2863 466 to 1   tiling clone, to resequence,   466/474
(98 %)
0 diff
(100 %id)
AI472170 pooled .f-u 2424 to 2863 474 to 36   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 439/439
(100 %)
6 diff
(98.7 %id)
CX867035 embryonic stem .f-u 2517 to 2863 1 to 347   AAA Submitted on the opposite strand 347/347
(100 %)
0 diff
(100 %id)
CX867107 embryonic stem .f-u 2517 to 2863 375 to 29   AAA Submitted on the opposite strand 347/347
(100 %)
0 diff
(100 %id)
AL036780 brain .f-u 2518 to 2863 28 to 374   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 347/374
(92 %)
5 diff
(98.7 %id)
CA312966 Human Lung Epithelial cells, lung .f-u 2518 to 2859 539 to 198   AAA   342/557
(61 %)
0 diff
(100 %id)
AV704234 adrenal gland .f-u 2519 to 2864 646 to 300   AAA Submitted on the opposite strand 347/432
(80 %)
0 diff
(100 %id)
CB250702 Human Lung Epithelial cells, lung .f-u 2521 to 2863 361 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 343/376
(91 %)
0 diff
(100 %id)
CA311794 Human Lung Epithelial cells, lung .f-u 2522 to 2682 1 to 161     Submitted on the opposite strand 161/170
(94 %)
1 diff
(99.5 %id)
TI_151752468   .f-u 2525 to 2869 450 to 105   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 346/1262
(27 %)
1 diff
(100.0 %id)
BM701460 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f-u 2526 to 2862 16 to 352       337/352
(95 %)
8 diff
(97.8 %id)
BM716834 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f-u 2526 to 2869 16 to 359   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 344/359
(95 %)
6 diff
(98.4 %id)
FN081259 breast carcinoma .f-u 2527 to 2616 1 to 90       90/91
(98 %)
1 diff
(99.0 %id)
AI651834 pooled germ cell tumors .f-u 2533 to 2821 1 to 289     Submitted on the opposite strand 289/289
(100 %)
3 diff
(99.0 %id)
AA865370 pooled germ cell tumors .f-u 2541 to 2863 341 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 323/323
(100 %)
0 diff
(100 %id)
C15566   .f-u 2587 to 2863 1 to 275       275/275
(100 %)
3 diff
(99.0 %id)
D53186   .f-u 2587 to 2863 1 to 277   fully sequenced,   277/277
(100 %)
3 diff
(99.0 %id)
D61035   .f-u 2587 to 2863 1 to 277       277/277
(100 %)
1 diff
(99.7 %id)
C14848   .f-u 2597 to 2838 9 to 246   fully sequenced,   238/246
(96 %)
24 diff
(90.3 %id)
AW593733 pooled germ cell tumors .f-u 2625 to 2869 256 to 12   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 245/245
(100 %)
0 diff
(100 %id)
CN313103 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f-u 2650 to 2864 1 to 215   AAA   215/296
(72 %)
1 diff
(99.7 %id)
D57375   .f-u 2654 to 2871 1 to 218   tiling clone,   218/218
(100 %)
0 diff
(100 %id)
AA470934 alveolar rhabdomyosarcoma .f-u 2654 to 2838 186 to 2       185/188
(98 %)
0 diff
(100 %id)
C14847   .f-u 2697 to 2863 163 to 1   fully sequenced,   163/163
(100 %)
1 diff
(99.4 %id)
AW242347 Kidney .f-u 2699 to 2862 184 to 20   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 165/165
(100 %)
8 diff
(95.2 %id)
D60354   .f-u 2703 to 2863 161 to 1   fully sequenced,   161/161
(100 %)
1 diff
(99.4 %id)
AA251368 germinal center B cell .g-u 1 to 435 1 to 434 exact tiling clone,   434/434
(100 %)
1 diff
(99.8 %id)
AA460556   .g-u 36 to 344 1 to 309 exact tiling clone,   309/309
(100 %)
0 diff
(100 %id)
AW967509   .g-u 448 to 1134 687 to 1   tiling clone, Submitted on the opposite strand 687/687
(100 %)
3 diff
(99.6 %id)
AW971528   .g-u 636 to 1134 499 to 1     Submitted on the opposite strand 499/535
(93 %)
10 diff
(98.2 %id)
AA251235 germinal center B cell .g-u 661 to 1135 475 to 1   tiling clone,   475/475
(100 %)
1 diff
(99.8 %id)
AA460557   .g-u 683 to 1139 457 to 1   tiling clone,   457/457
(100 %)
1 diff
(99.8 %id)
AA834858 ovary .g-u 847 to 1135 1 to 289   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 289/289
(100 %)
0 diff
(100 %id)
AW851124 colon .h-u 1 to 507 34 to 540   tiling clone,   507/540
(93 %)
6 diff
(98.9 %id)
AA682507 liver and spleen .h-u 443 to 894 452 to 1 H15Y tiling clone,   452/452
(100 %)
2 diff
(99.6 %id)
CV802065 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .i-u 1 to 737 1 to 728 exact tiling clone,   728/847
(85 %)
11 diff
(98.8 %id)
BX954765   .j-u 1 to 621 1 to 621 exact tiling clone,   621/621
(100 %)
3 diff
(99.6 %id)
BI061925 uterus_tumor .k-u 1 to 470 1 to 470 exact tiling clone,   470/470
(100 %)
0 diff
(100 %id)
BI062483 uterus_tumor .k-u 7 to 507 501 to 1 exact tiling clone,   501/501
(100 %)
0 diff
(100 %id)
G36918   .l-u 1 to 471 1 to 470 A63D     470/470
(100 %)
5 diff
(99.0 %id)
N68480 liver and spleen .l-u 1 to 471 1 to 470 A63D tiling clone, Submitted on the opposite strand 470/470
(100 %)
5 diff
(99.0 %id)
BF222976 pooled germ cell tumors .m-u 1 to 362 362 to 1 exact tiling clone,   362/362
(100 %)
2 diff
(99.5 %id)
AW999532 breast_normal .m-u 77 to 218 1 to 142       142/142
(100 %)
0 diff
(100 %id)
BE770563 prostate_tumor .n-u 1 to 269 12 to 279 I13L K22Q R31K K32G M33N ... tiling clone,   268/279
(96 %)
6 diff
(97.9 %id)
BX109124 ovary, tumor, 5 pooled (see description) Gene WDR43, variant not shown       AAA      
BP872388 embryonal kidney Gene WDR43, variant not shown         This clone was ignored    
BP872775 embryonal kidney Gene WDR43, variant not shown         This clone was ignored    
AI609327 ovary, tumor, 5 pooled (see description) Gene WDR43, variant not shown              
BG032708 breast, mammary adenocarcinoma, cell line Gene WDR43, variant not shown         Suspected internal deletion, this clone was ignored    
BG142241 Islets of Langerhans, Pancreas Gene WDR43, variant not shown         This clone was ignored    
CB133931 Liver Gene WDR43, variant not shown         Suspected internal deletion, this clone was ignored    
DB071875 testis Gene WDR43, variant not shown       capped      
DB340265 testis Gene WDR43, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g-u, .h-u, .i-u, .j-u, .k-u, .l-u, .m-u, .n-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C